Multiple myeloma includes phenotypically defined subsets of clonotypic CD20+ B cells that persist during treatment with rituximab
Linda M Pilarski,
Eva Baigorri,
Michael J Mant,
Patrick M Pilarski,
Penelope Adamson,
Heddy Zola,
Andrew R Belch
January, 2008